Q4 2022 Holdings
Filed 2023-02-01 | 63 holdings | $323.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Horizon Therapeutics PLC | SHS | G4617B105 | $35.8M | 314,973 | 11.1% |
| Seagen Inc COM(SGENUSD) | COM | 81181C104 | $21.4M | 166,200 | 6.6% |
| Incyte Corp Inc COM(INCY) | COM | 45337C102 | $18.4M | 229,000 | 5.7% |
| Alkermes PLC SHS(ALKS) | SHS | G01767105 | $15.5M | 593,000 | 4.8% |
| Harmony Biosciences Holdi(HRMY) | COM | 413197104 | $14.6M | 264,500 | 4.5% |
| Uniqure N.V. COM Eur0.05(QURE) | SHS | N90064101 | $14.3M | 631,500 | 4.4% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $13.7M | 383,500 | 4.2% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $11.7M | 221,856 | 3.6% |
| Mirati Therapeutics Inc C(MRTXEUR) | COM | 60468T105 | $11.1M | 244,000 | 3.4% |
| Illumina Inc COM(ILMN) | COM | 452327109 | $9.4M | 46,500 | 2.9% |
| Alnylam Pharmaceuticals I(ALNY) | COM | 02043Q107 | $9.0M | 38,000 | 2.8% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $8.9M | 340,389 | 2.8% |
| Exelixis Inc COM(EXEL) | COM | 30161Q104 | $8.7M | 543,000 | 2.7% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $8.1M | 11,200 | 2.5% |
| Ultragenyx Pharmaceutical(RARE) | COM | 90400D108 | $8.1M | 174,052 | 2.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $8.0M | 379,019 | 2.5% |
| Dyne Therapeutics Inc COM(DYN) | COM | 26818M108 | $7.4M | 641,068 | 2.3% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $6.9M | 143,500 | 2.1% |
| Biogen Inc Common Stock(BIIB) | COM | 09062X103 | $5.9M | 21,400 | 1.8% |
| PTC Therapeutics Inc COM(PTCT) | COM | 69366J200 | $5.5M | 144,000 | 1.7% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $5.4M | 281,257 | 1.7% |
| Gilead Sciences Inc Commo(GILD) | COM | 375558103 | $4.9M | 57,584 | 1.5% |
| Biomarin Pharmaceutical I(BMRN) | COM | 09061G101 | $4.5M | 43,656 | 1.4% |
| Astrazeneca PLC Sponsored(AZN) | SPONSORED ADR | 046353108 | $4.4M | 65,000 | 1.4% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $4.3M | 16,246 | 1.3% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $4.2M | 15,000 | 1.3% |
| Ascendis Pharma A/S Spons(ASND) | Sponsored ADR | 04351P101 | $3.6M | 29,400 | 1.1% |
| Krystal Biotech Inc COM(KRYS) | COM | 501147102 | $3.6M | 45,000 | 1.1% |
| Beigene LTD Sponsored ADR(ONC) | Sponsored ADR | 07725L102 | $3.5M | 15,700 | 1.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $2.7M | 17,200 | 0.8% |
| Aurinia Pharmaceuticals I(AUPH) | COM | 05156V102 | $2.5M | 573,530 | 0.8% |
| ZAI LAB LTD ADR(ZLAB) | ADR | 98887Q104 | $2.4M | 78,958 | 0.7% |
| Novocure Ltd(NVCR) | ORD SHS | G6674U108 | $2.3M | 32,000 | 0.7% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $2.2M | 120,000 | 0.7% |
| Guardant Health Inc COM(GH) | COM | 40131M109 | $2.0M | 74,500 | 0.6% |
| Ideaya Biosciences Inc Co(IDYA) | COM | 45166A102 | $2.0M | 109,000 | 0.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $1.9M | 38,000 | 0.6% |
| Apellis Pharmaceuticals I(APLS) | COM | 03753U106 | $1.6M | 31,700 | 0.5% |
| Caribou Biosciences Inc C(CRBU) | COM | 142038108 | $1.6M | 257,892 | 0.5% |
| Acadia Pharmaceuticals in(ACAD) | COM | 004225108 | $1.6M | 100,000 | 0.5% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.4M | 193,741 | 0.4% |
| Crispr Therapeutics AG Co(CRSP) | NAMEN AKT | H17182108 | $1.4M | 34,200 | 0.4% |
| Adicet BIO Inc COM(TORCEUR) | COM | 007002108 | $1.4M | 154,708 | 0.4% |
| Novavax Inc(NVAX) | COM | 670002401 | $1.4M | 132,500 | 0.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.3M | 67,500 | 0.4% |
| I-Mab Sponsored ADS(NBP) | SPONSORED ADS | 44975P103 | $1.3M | 310,499 | 0.4% |
| Rocket Pharmaceuticals in(RCKT) | COM | 77313F106 | $1.2M | 63,000 | 0.4% |
| Concert Pharmaceuticals I(CNCEEUR) | COM | 206022105 | $1.2M | 200,800 | 0.4% |
| Denali Therapeutics Inc C(DNLI) | COM | 24823R105 | $1.1M | 38,000 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.0M | 25,500 | 0.3% |